279 related articles for article (PubMed ID: 35133485)
1. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
[TBL] [Abstract][Full Text] [Related]
3. Multicenter clinical radiomics-integrated model based on [
Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
[TBL] [Abstract][Full Text] [Related]
4. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
[TBL] [Abstract][Full Text] [Related]
7. MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.
Wu C; Zheng H; Li J; Zhang Y; Duan S; Li Y; Wang D
Eur Radiol; 2022 Mar; 32(3):1813-1822. PubMed ID: 34655310
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.
Zhou W; Wen J; Huang Q; Zeng Y; Zhou Z; Zhu Y; Chen L; Guan Y; Xie F; Zhuang D; Hua T
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1423-1435. PubMed ID: 38110710
[TBL] [Abstract][Full Text] [Related]
9. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
10. Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas.
Huo X; Wang Y; Ma S; Zhu S; Wang K; Ji Q; Chen F; Wang L; Wu Z; Li W
Medicine (Baltimore); 2023 Dec; 102(51):e36581. PubMed ID: 38134061
[TBL] [Abstract][Full Text] [Related]
11. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
12. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
[TBL] [Abstract][Full Text] [Related]
13. A fusion model integrating magnetic resonance imaging radiomics and deep learning features for predicting alpha-thalassemia X-linked intellectual disability mutation status in isocitrate dehydrogenase-mutant high-grade astrocytoma: a multicenter study.
Liu Z; Xu X; Zhang W; Zhang L; Wen M; Gao J; Yang J; Kan Y; Yang X; Wen Z; Chen S; Cao X
Quant Imaging Med Surg; 2024 Jan; 14(1):251-263. PubMed ID: 38223098
[TBL] [Abstract][Full Text] [Related]
14. ATRX status in patients with gliomas: Radiomics analysis.
Meng L; Zhang R; Fa L; Zhang L; Wang L; Shao G
Medicine (Baltimore); 2022 Sep; 101(37):e30189. PubMed ID: 36123880
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prediction of IDH mutation status in gliomas using preoperative multiparametric MRI radiomics nomogram: A mutlicenter study.
Lu J; Xu W; Chen X; Wang T; Li H
Magn Reson Imaging; 2023 Sep; 104():72-79. PubMed ID: 37778708
[TBL] [Abstract][Full Text] [Related]
16. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract][Full Text] [Related]
17. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L
J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
[TBL] [Abstract][Full Text] [Related]
20. Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Tabatabai G; Bender B; Ernemann U; Klose U
Clin Neuroradiol; 2018 Sep; 28(3):421-428. PubMed ID: 28488024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
